Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
LLY - Eli Lilly and Company
Market Cap 431.43B P/E 72.14 EPS this Y -16.20% Ern Qtrly Grth -
Income 4.99B Forward P/E 42.44 EPS next Y 85.00% 50D Avg Chg 1.00%
Sales 32.07B PEG 3.10 EPS past 5Y -7.69% 200D Avg Chg 19.00%
Dividend 1.00% Price/Book 36.52 EPS next 5Y 28.72% 52W High Chg -3.00%
Recommedations 1.90 Quick Ratio 0.58 Shares Outstanding 0.95B 52W Low Chg 53.00%
Insider Own 0.15% ROA 11.63% Shares Float 897.74M Beta 0.33
Inst Own 83.99% ROE 46.46% Shares Shorted/Prior 5.84M/6.39M Price 454.48
Gross Margin 78.67% Profit Margin 15.55% Avg. Volume 2,662,108 Target Price 627.47
Oper. Margin 37.28% Earnings Date Feb 6 Volume 2,365,805 Change 0.31%
Healthcare | Drug Manufacturers - General | United States
About Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Eli Lilly and Company News
11/28/23 Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives
11/28/23 Is Eli Lilly Stock A Buy After Mounjaro Beats Out Ozempic In A Head-To-Head Analysis?
11/28/23 Dow Jones Leader Visa, Chip Giant AMD Are Best Stocks To Buy And Watch
11/28/23 Lilly’s Mounjaro Outperforms Novo’s Ozempic in Real-World Study
11/28/23 3 Large Drug Stocks That Have Outperformed Industry YTD
11/28/23 A Look At The Fair Value Of Eli Lilly and Company (NYSE:LLY)
11/28/23 Lilly Announces Plans to Open its First-ever Gateway Labs Site in San Diego
11/28/23 Alexandria Real Estate Equities, Inc. Announces Exclusive Partnership With Lilly to Expand Lilly Gateway Labs to San Diego
11/28/23 The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
11/28/23 10 Top Stock Picks of Israel Englander
11/28/23 20 Countries With the Most Centenarians (People Over 100)
11/27/23 11 Best Stocks to Buy for High Returns
11/27/23 Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs
11/27/23 Novo to expand French plant in GLP-1 production push
11/27/23 ‘I want to scream’: Jim Cramer is adamant that analysts are 'insane' to be so wary of ‘revolutionary’ weight-loss drugs like Ozempic — here’s why the TV host is so bullish on these stocks
11/27/23 The Zacks Analyst Blog Highlights Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce
11/27/23 Novo Nordisk CEO: Willing to be "flexible" on Wegovy pricing schemes - FT
11/26/23 Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
11/26/23 Goldman Sachs’ Top 15 Stock Picks for 2024
11/26/23 3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
LLY Chatroom

User Image stockilluminati Posted - 3 hours ago

$LLY https://www.stockilluminati.com/lly/earnings.php - Experience the power of predictive analytics with our Earnings Call Sentiment Analysis There were 88 positive comments, 45 negative comments and 414 neutral comments

User Image stockilluminati Posted - 3 hours ago

$LLY https://www.stockilluminati.com/lly/news.php - Eli Lilly and Company (LLY) Presents at 6th Evercore ISI HealthCONx Conference (Transcript)

User Image cctranscripts Posted - 3 hours ago

Going through explanations advanced in $LLY conf call transcript https://conferencecalltranscripts.com/summary/?id=535713&pr=true

User Image ROCKET123 Posted - 4 hours ago

$LLY $NVO https://www.yahoo.com/lifestyle/weight-loss-drugs-ozempic-wegovy-complications-020706382.html

User Image sniperrr Posted - 5 hours ago

$LLY comment section is very bullish but the 3 day chart all the way to the weekly chart says a drop is coming

User Image JacoI3 Posted - 7 hours ago

@Neng1987 @DonCorleone77 I think it’s good… I think $LLY decided to max out their position after the phase I results.

User Image RandyWatsonSexyChocolate Posted - 8 hours ago

$LLY Go hard one-time for Charlie!

User Image ChrisH76 Posted - 8 hours ago

$LLY strong close. That’s positive

User Image DrumpFish Posted - 8 hours ago

$LLY so fkn annoying

User Image Nokooks1978 Posted - 8 hours ago

$LLY Tired of watching this BS. Rolling everything over to Jan March. F off shorts

User Image davidfr Posted - 8 hours ago

$LLY Down on very low volume today vs. 10 day average? Big rebound is due sooner!! Buy and hold for the win!

User Image GREENCANDLELOVER Posted - 8 hours ago

$LLY playing games until news of pharmacies stocked with ZEPBOUND

User Image AE4328 Posted - 8 hours ago

$LLY I’m trying

User Image GREENCANDLELOVER Posted - 8 hours ago

$LLY when they announce ZEPBOUND is stocked at pharmacies… major spike.

User Image Ralphiesrevenge Posted - 8 hours ago

$LLY watch me take a loss and this shit run to 620 again

User Image JGNYC Posted - 10 hours ago

$LLY who’s holding this downpour

User Image impact80 Posted - 10 hours ago

$LLY $595 by close

User Image Nokooks1978 Posted - 11 hours ago

$LLY The fuckery continues on low volume again. Someone needs this down through month end it appears..

User Image GettnFibbywIT Posted - 11 hours ago

$LLY $XLV From Mid September to Mid October 2023, you could see a price + momentum divergence developing, with price subsequently falling back into a rising channel and then making another attempt at the upper channel line which acted like resistance, and thus creating (2) lower highs as momementum indicators continued to deteriorate underneath. Price is currently consolidating, with relatively small "real body" candles, and currently trading between the 10 dma (pointing down) and above the 20 dma in a tight range. Momentum indicators are down to flat, with price consolidating within a shorter term triangle. Upward price momentum appears to be muted, with a shorter term bias of sideways to down until a convincing upward move above the shorter term downward diagonal (dotted) resistance line (1 - 2).

User Image T7Boeing Posted - 11 hours ago

$CRSP https://www.fiercepharma.com/pharma/scottish-stem-cell-pro-roslinct-inks-landmark-production-pact-make-vertex-and-crisprs-gene $VTRX $NTLA $REGN $LLY

User Image dmas Posted - 11 hours ago

$LLY $NVO @Arooba2 you really expect $NVO earnings report to say, SELECT study was a disappointment, the Asian "Launch" in Japan was a mistake and its a case of too little, too late to manage the supply chain / manufacturing issues ?

User Image STCKPRO Posted - 11 hours ago

$LLY NEW ARTICLE : Eli Lilly (NYSE:LLY) Pops Up After Beating Novo Nordisk (NYSE:NVO) In Weight Loss https://www.stck.pro/news/LLY/68789903/

User Image Ralphiesrevenge Posted - 12 hours ago

$LLY pos

User Image dmas Posted - 12 hours ago

$NVO down. $LLY is up. If $LLY stock splits something like 6:1, then $NVO is toast. :-)

User Image jewell69 Posted - 12 hours ago

trying to pile on $LLY GTC 593.20 NOW b/a .44 x .74 I already own some

User Image I_like_em_stock Posted - 12 hours ago

$LLY a year from now "you remember when LLY was under $600"

User Image DonCorleone77 Posted - 12 hours ago

$LLY $NVO Lilly's Mounjaro more effective than Ozempic for weight loss in study, CNBC says Eli Lilly's (LLY) diabetes drug Mounjaro is more effective for weight loss than Novo Nordisk's (NVO) Ozempic in overweight or obese adults, according to a large analysis of real-world data, CNBC's Annika Kim Constantino reports. Patients taking Mounjaro were significantly more likely to lose 5%, 10% and 15% of their body weight overall and saw larger reductions in body weight after three months, six months and a year compared with those on Ozempic in the study by Truveta Research. The study is not yet peer-reviewed, CNBC notes.

User Image Teslaratiking Posted - 13 hours ago

$GME buy some $NVAX also its about that time 🚀 $LLY $MRNA $SPY

User Image howardlindzon Posted - 13 hours ago

Magic Pills may finally be coming https://www.wsj.com/articles/magic-pills-are-coming-healthcare-cost-parkinsons-cancer-addiction-depression-e3c392fa?st=5cwto4fos08hbsv&reflink=article_email_share I do like Idea of ai medical chatbots as my doctor treats me like a bot and so I dont trust him... $lly $xbi

User Image patriciaedna1954 Posted - 13 hours ago

$LLY

Analyst Ratings
Cantor Fitzgerald Overweight Nov 20, 23
Cantor Fitzgerald Overweight Nov 17, 23
Cantor Fitzgerald Overweight Nov 15, 23
Deutsche Bank Hold Nov 9, 23
JP Morgan Overweight Nov 8, 23
Morgan Stanley Overweight Nov 3, 23
Citigroup Buy Oct 23, 23
Cantor Fitzgerald Overweight Oct 23, 23
Morgan Stanley Overweight Oct 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LILLY ENDOWMENT INC Director Director Aug 08 Sell 521.62 204,409 106,623,823 100,823,810 08/09/23
LILLY ENDOWMENT INC Director Director Jul 21 Sell 466.621 591 275,773 101,028,219 07/24/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 29 Sell 465.083 44,115 20,517,137 101,192,935 06/30/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 22 Sell 458.99 107,022 49,122,028 101,248,810 06/23/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 21 Sell 454.54 31,454 14,297,101 101,355,832 06/22/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 15 Sell 454.59 27,353 12,434,400 101,446,457 06/16/23
LILLY ENDOWMENT INC 10% Owner 10% Owner May 19 Sell 444.92 194,354 86,471,982 101,473,810 05/22/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 06 Sell 367.21 130,297 47,846,361 102,133,810 04/07/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 05 Sell 363.72 69,703 25,352,375 102,264,107 04/06/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 31 Sell 342.71 205,000 70,255,550 102,543,810 04/03/23
LILLY ENDOWMENT INC 10% Owner 10% Owner Dec 02 Sell 372.97 49,089 18,308,724 102,948,810 12/05/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Dec 01 Sell 373.31 160,911 60,069,685 102,997,899 12/02/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Nov 07 Sell 364.42 63,585 23,171,646 103,158,810 11/08/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Nov 02 Sell 362.07 6,131 2,219,851 103,357,679 11/03/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Oct 18 Sell 334.29 12,042 4,025,520 103,529,293 10/19/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Oct 14 Sell 334.42 3,187 1,065,797 103,620,959 10/17/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Oct 06 Sell 336.56 149,264 50,236,292 103,624,546 10/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Sep 28 Sell 336.99 101,631 34,248,631 103,773,810 09/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 28 Sell 333.18 89,458 29,805,616 103,875,441 07/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 26 Sell 332.524 1,601 532,371 103,964,899 07/27/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 15 Sell 334 17,310 5,781,540 103,966,500 07/18/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jul 06 Sell 330.88 177,243 58,646,164 103,983,810 07/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 28 Sell 329.01 900 296,109 104,161,053 06/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 27 Sell 329.045 41,857 13,772,837 104,161,953 06/28/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 24 Sell 323.95 215,000 69,649,250 104,203,810 06/27/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 23 Sell 311.37 205,000 63,830,850 104,418,810 06/24/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Jun 22 Sell 307.35 210,000 64,543,500 104,623,810 06/23/22
Zakrowski Donald A Chief Accounting Off.. Chief Accounting Officer Jun 01 Sell 313.44 1,000 313,440 6,274 06/02/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 25 Sell 309.36 41,610 12,872,470 105,212,200 05/26/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 24 Sell 306.01 100,000 30,601,000 105,253,810 05/25/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 23 Sell 303.37 118,856 36,057,345 105,353,810 05/24/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 18 Sell 302.00 700 211,400 105,472,666 05/19/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 17 Sell 302.73 19,683 5,958,635 105,473,366 05/18/22
LILLY ENDOWMENT INC 10% Owner 10% Owner May 16 Sell 302.75 80,761 24,450,393 105,493,049 05/17/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 08 Sell 310.88 139,045 43,226,310 105,573,810 04/11/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 06 Sell 301.11 51,851 15,612,855 105,783,810 04/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 05 Sell 294.4 113,756 33,489,766 105,835,661 04/06/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Apr 04 Sell 293.152 39,393 11,548,137 105,949,417 04/05/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 30 Sell 292.03 2,500 730,075 106,154,186 03/31/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 28 Sell 292.155 7,538 2,202,264 106,161,027 03/29/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 18 Sell 288.4 210,000 60,564,000 106,203,810 03/21/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 17 Sell 283.95 220,000 62,469,000 106,413,810 03/18/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 15 Sell 273.77 220,075 60,249,933 106,633,810 03/16/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 14 Sell 269.73 173,085 46,686,217 106,853,885 03/15/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 11 Sell 269.047 21,840 5,875,986 107,026,970 03/14/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 10 Sell 266.8 184,982 49,353,198 107,048,810 03/11/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 09 Sell 266.94 20,018 5,343,605 107,233,792 03/10/22
Runge Marschall S Director Director Mar 01 Buy 246.78 202 49,850 15,436 03/07/22
LILLY ENDOWMENT INC 10% Owner 10% Owner Mar 04 Sell 262.14 210,000 55,049,400 107,253,810 03/07/22
Jonsson Patrik SVP&Pres, LLY Imm, L.. SVP&Pres, LLY Imm, LLY USA&CCO Mar 01 Sell 247.56 675 167,103 32,035 03/03/22